Opening the Blood-Brain Barrier and Improving the Efficacy of Temozolomide Treatments of Glioblastoma Using Pulsed, Focused Ultrasound with a Microbubble Contrast Agent

Figure 7

Western blot detection of Ki-67 (means ± SD, n = 3). Ki-67 expression in the tumor tissue was less in the test group than in the control group.